ChomiX Biotech, a Nanjing, China-based biotechnology company focusing on the preclinical development of innovative small molecule drugs, raised an undisclosed amount in Series Pre-A+...
ecoSPIRITS, a Singapore-based circular economy technology company focusing on low carbon, low waste distribution systems for the premium wine and spirits industry, raised $10M...
Cullgen, Inc., a San Diego, CA and Shangai, China-based biotechnology company developing small molecule therapeutics based on its proprietary uSMITE™ platform of targeted protein...
Pudu Robotics, a Shenzhen, China-based company which specializes in commercial service robots, raised hundreds of millions of yuan in its C4 financing round.
The backers...
Adcentrx Therapeutics, a San Diego, CA and Shangai, China-based biotechnology company dedicated to advancing Antibody-Drug Conjugate (ADC) therapeutics for cancer and other life-threatening diseases,...
Ankura Consulting Group, a London, UK-based independent services and advisory firm, acquired GreenPoint Group, a US-China strategic advisory firm focused on corporations and non-profit...
Chamlion, a Nanjing, China-based company focused on the digitalization of processes of dentistry, raised 236M Yuan in Series B funding.
The round was led by...
SJ Semiconductor Corporation, a JianGyin, China-based provider of first-class Middle-End-Of-Line (MEOL) manufacturing and testing services, signed $340m Series C+ financing.
The closing of US dollar...
DeepWay, a Beijing, China-based smart commercial vehicle developer and manufacturer, raised ￥770M in Series A+ funding.
The round was led by Shandong Weiqiao Pioneering Group...
SiYi Intelligence, a Shangai, China-based intelligent rehabilitation solution provider, completed nearly USD15m in Series A financing.
The round was led by Chengdu Bio-town Equity Investment Fund...
Zhuhai Kingsware Information Technology, a Zhuhai, China-based provider big data processing, information system integration, and other services, raised RMB 500M in Series C+ funding.
The...
TandemAI, a Suzhou, and Shanghai, China- and New York-based technology company focused on transforming drug discovery infrastructure, raised $35M in Series A funding.
The round...
